Investigating how androgen signaling affects prostate cancer development

A new and non-autonomous role of androgen signaling in prostate tumorigenesis

NIH-funded research Albert Einstein College of Medicine · NIH-11030922

This study is looking at how hormones called androgens affect prostate cancer growth, especially when standard treatments aren't working, to find new ways to help patients with advanced prostate cancer feel better and live longer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine NIH-funded
Lab location1 site (Bronx, United States)
Project IDNIH-11030922 on NIH RePORTER

What this research studies

This research explores the role of androgen signaling, particularly through the androgen receptor, in the development of prostate cancer. It aims to understand how androgen signaling in the surrounding stromal cells influences the growth of prostate tumors, especially in cases where traditional androgen deprivation therapies fail. By examining the interactions between prostate epithelial cells and their stromal environment, the study seeks to uncover new therapeutic strategies for advanced prostate cancer. Patients may benefit from insights that could lead to more effective treatments for those with castration-resistant prostate cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research are American men diagnosed with advanced prostate cancer, particularly those who have developed resistance to androgen deprivation therapy.

Not a fit: Patients with early-stage prostate cancer or those who have not undergone androgen deprivation therapy may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients with advanced prostate cancer who do not respond to current therapies.

How similar studies have performed: Other research has shown promising results in understanding the role of stromal interactions in cancer progression, suggesting that this approach may yield valuable insights.

Where this research is happening

Bronx, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions advanced prostate cancerandrogen independent prostate cancerandrogen indifferent prostate cancerandrogen insensitive prostate cancer
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.